Skip to main content
Top
Published in: Current Atherosclerosis Reports 3/2007

01-05-2007

High-density lipoprotein: Antioxidant and anti-inflammatory properties

Authors: Mohamad Navab, PhD, Roger Yu, MD, Nima Gharavi, PhD, William Huang, BSc, Navid Ezra, BSc, Ali Lotfizadeh, MD, G. M. Anantharamaiah, PhD, Nima Alipour, MSc, Brian J. Van Lenten, PhD, Srinivasa T. Reddy, PhD, Daniel Marelli, MD

Published in: Current Atherosclerosis Reports | Issue 3/2007

Login to get access
Metadata
Title
High-density lipoprotein: Antioxidant and anti-inflammatory properties
Authors
Mohamad Navab, PhD
Roger Yu, MD
Nima Gharavi, PhD
William Huang, BSc
Navid Ezra, BSc
Ali Lotfizadeh, MD
G. M. Anantharamaiah, PhD
Nima Alipour, MSc
Brian J. Van Lenten, PhD
Srinivasa T. Reddy, PhD
Daniel Marelli, MD
Publication date
01-05-2007
Publisher
Current Science Inc.
Published in
Current Atherosclerosis Reports / Issue 3/2007
Print ISSN: 1523-3804
Electronic ISSN: 1534-6242
DOI
https://doi.org/10.1007/s11883-007-0026-3

Other articles of this Issue 3/2007

Current Atherosclerosis Reports 3/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine